Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shinichiro Muro is active.

Publication


Featured researches published by Shinichiro Muro.


Digestive Endoscopy | 2015

Double-balloon enteroscopy for choledochojejunal anastomotic stenosis after hepato-biliary-pancreatic operation.

Ichiro Sakakihara; Hironari Kato; Shinichiro Muro; Yasuhiro Noma; Naoki Yamamoto; Ryo Harada; Shigeru Horiguchi; Koichiro Tsutsumi; Hiroyuki Okada; Kazuhide Yamamoto; Hiroshi Sadamori; Takahito Yagi

There have been few reports on the success rate of balloon dilation and stent deployment using endoscopic retrograde cholangiopancreatography by double‐balloon enteroscopy (DBE‐ERCP) or on the follow‐up period after stent removal in patients with a reconstructed digestive tract and stenosis of choledochojejunal anastomosis. The present study was designed to evaluate the usefulness of DBE‐ERCP in patients with a reconstructed digestive tract and stenosis of choledochojejunal anastomosis.


Digestion | 2015

Serum anti-60S ribosomal protein L29 antibody as a novel prognostic marker for unresectable pancreatic cancer.

Shinichiro Muro; Yasuhiro Miyake; Hironari Kato; Koichiro Tsutsumi; Kazuhide Yamamoto

Background/Aims: Recently, we found the presence of anti-60S ribosomal protein L29 antibody (anti-RPL29) in human sera, inhibiting the proliferation of pancreatic cancer cells in vitro. We aimed to estimate the association of serum anti-RPL29 levels with clinical features in patients affected with unresectable pancreatic cancer. Methods: We retrospectively reviewed 105 patients with unresectable pancreatic cancer. Serum anti-RPL29 levels were measured by the indirect enzyme-linked immunosorbent assay. The cut-off was represented by the 95th percentile in 62 healthy volunteers. Results: Median survival time (MST) was 11.1 months in 49 patients showing serum anti-RPL29 level >cut-off and 7.4 months in 56 patients showing serum anti-RPL29 level ≤cut-off. In locally advanced disease, MST was 17.9 months in 22 patients showing serum anti-RPL29 level >cut-off and 10.0 months in 19 patients showing serum anti-RPL29 level ≤cut-off. In metastatic disease, MST was 8.7 months in 27 patients showing serum anti-RPL29 level >cut-off and 5.9 months in 37 patients showing serum anti-RPL29 level ≤cut-off. In the multivariate Cox proportional hazard model, serum anti-RPL29 level >cut-off, abdominal or back pain, performance status, and metastatic disease were identified as independent prognostic factors. Conclusion: Serum anti-RPL29 levels may be a novel candidate for a prognostic marker for unresectable pancreatic cancer.


Journal of Clinical Gastroenterology | 2014

Efficacy of Endoscopic Over 3-branched Partial Stent-in-Stent Drainage Using Self-expandable Metallic Stents in Patients With Unresectable Hilar Biliary Carcinoma.

Daisuke Uchida; Hironari Kato; Shinichiro Muro; Yasuhiro Noma; Naoki Yamamoto; Shigeru Horiguchi; Ryo Harada; Koichiro Tsutsumi; Hirofumi Kawamoto; Hiroyuki Okada; Kazuhide Yamamoto

Background: The treatment of biliary stricture is crucially important for continuing stable chemotherapy for unresectable biliary carcinoma; however, there is no consensus regarding the use of hilar biliary drainage. In this study, we examined the efficacy of endoscopic over 3-branched biliary drainage using self-expandable metallic stents (SEMSs) in patients with unresectable malignant hilar biliary stricture (HBS). Methods: A total of 77 patients with unresectable HBS treated with a SEMS and chemotherapy were retrospectively reviewed. There were 59 patients with cholangiocarcinoma and 18 patients with gallbladder carcinoma. The patients were divided into 2 groups (4- or 3-branched group and 2- or 1-branched group) and compared with respect to the duration of stent patency and overall survival. Results: A comparison of the patients’ baseline characteristics showed no significant differences between the 4- or 3-branched group and the 2- or 1-branched group. Neither the duration of patency nor survival time exhibited significant differences between the 2 groups, although, among the patients achieving disease control , the duration of patency period and survival time of the 4- or 3-branched group were significantly higher than those observed in the 2- or 1-branched group (P=0.0231 and 0.0466). Conclusions: The use of endoscopic over 3-branched biliary drainage with a SEMS may improve the duration of patency in patients with HBS.


Endoscopy | 2017

Usefulness of a newly designed plastic stent for endoscopic re-intervention in patients with malignant hilar biliary obstruction

Takeshi Tomoda; Hironari Kato; Hirofumi Kawamoto; Shinichiro Muro; Yutaka Akimoto; Daisuke Uchida; Kazuyuki Matsumoto; Shigeru Horiguchi; Koichiro Tsutsumi; Hiroyuki Okada

Background and study aims We designed a new 7-Fr plastic stent for treating self-expandable metal stent (SEMS) obstruction in patients with malignant hilar biliary obstruction (MHBO) via endoscopic re-intervention with the stent-in-stent (SIS) method and evaluated its efficacy. Patients and methods A total of 33 consecutive patients who underwent endoscopic re-intervention for metal stent obstruction after multi-branched SEMS placement were enrolled. The initial SEMSs were placed in two or three biliary branches in 14 and 19 patients, respectively. We retrospectively evaluated the technical and clinical success, and adverse events. Technical success was defined as successful plastic stent placement into all target branches through the lumen of the SEMS. Results The technical success rates were 85.7 % (12/14) and 78.9 % (15/19) in patients who underwent two- or three-branched biliary drainage, respectively. The clinical success rate was 100 % in the 27 patients in whom technical success was achieved. We achieved successful plastic stent placement in more than two branches, using the new plastic stent combined with a conventional plastic stent, in 97.0 % (32/33). Conclusions This new plastic stent was technically feasible for treating stent obstruction via re-intervention with SIS methods.


Digestive and Liver Disease | 2016

A case of polypoid lesions of the common bile duct observed on peroral video cholangioscopy

Shinichiro Muro; Hironari Kato; Soichiro Fushimi; Hiroyuki Okada

A 75-year-old male was admitted to our hospital with epigastric ain and serum liver enzyme abnormalities. Contrast-enhanced CT howed irregular thickening of the wall of the middle bile duct. RCP disclosed wall irregularities in the middle bile duct with a ranular filling defect, and peroral video cholangioscopy (PVCS) emonstrated many polypoid lesions extending from the bifurcaion of the cystic duct branch to the distal bile duct (Fig. 1 white ight (a), NBI (b)). A forceps biopsy of the lesions showed lymphoid ollicles without any evidence of malignancy histopathologically. owever, the patient underwent pancreaticoduodenectomy with xtrahepatic bile duct resection under suspicion of cholangiocarcioma.


Endoscopy International Open | 2018

Efficacy of endoscopic treatment using double-balloon enteroscopy for postoperative bile leakage in patients with hepaticojejunostomy

Kazuyuki Matsumoto; Koichiro Tsutsumi; Hironari Kato; Shigeru Horiguchi; Yosuke Saragai; Saimon Takada; Sho Mizukawa; Shinichiro Muro; Daisuke Uchida; Takeshi Tomoda; Hiroyuki Okada

Background and study aims  Endoscopic treatment for post-operative bile is technically challenging in patients with altered gastrointestinal anatomy. This study evaluated the effectiveness of using a short-type double-balloon enteroscope to treat postoperative bile leakage after hepaticojejunostomy.


Case reports in gastrointestinal medicine | 2018

Endoscopic Ultrasound-Guided Hepaticogastrostomy Is Effective for Repeated Recurrent Cholangitis after Surgery: Two Case Reports

Akihiro Matsumi; Hironari Kato; Yousuke Saragai; Sho Mizukawa; Saimon Takada; Shinichiro Muro; Daisuke Uchida; Takeshi Tomoda; Kazuyuki Matsumoto; Masaya Iwamuro; Shigeru Horiguchi; Yoshiro Kawahara; Hiroyuki Okada

We report the cases of two patients who underwent endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) using metallic stents (MS) for recurrent cholangitis due to benign biliary stenosis. The patients had repeatedly undergone double-balloon endoscopy and anastomotic stenosis. Thus, EUS-HGS was performed. The procedures were successful, and placement of a covered metallic stent (C-MS) relieved cholangitis. The occurrence of cholangitis was subsequently considerably reduced. For patients with postoperative recurrent cholangitis, EUS-HGS with MS should be considered because of its efficacy and safety.


Canadian Journal of Gastroenterology & Hepatology | 2018

Indications for Endoscopic Ultrasound-Guided Pancreatic Drainage: For Benign or Malignant Cases?

Daisuke Uchida; Hironari Kato; Yosuke Saragai; Saimon Takada; Sho Mizukawa; Shinichiro Muro; Yutaka Akimoto; Takeshi Tomoda; Kazuyuki Matsumoto; Shigeru Horiguchi; Hiroyuki Okada

Background and Aims Recurrent pancreatitis associated with pancreatic strictures requires treatment with endoscopic retrograde pancreatography (ERP), but it is sometimes technically unsuccessful. Endoscopic ultrasound-guided pancreatic drainage (EUS-PD) was developed as an alternative to a surgical approach after failed ERP; however, the indications for EUS-PD are unclear. In this study, we evaluated the outcomes of EUS-PD and established the indications for EUS-PD. Methods A total of 15 patients had indications for EUS-PD for recurrent pancreatitis due to pancreatic strictures. There were eight patients with benign pancreatic strictures and seven with malignant pancreatic strictures. The success rate, adverse events, and long-term outcomes were evaluated. Results The technical success rates of benign and malignant strictures were 75% (6/8) and 100% (7/7), respectively, and clinical success was achieved in 100% (6/6) and 87.5% of cases (6/7), respectively. Rendezvous procedures were performed in two patients with benign strictures. The adverse event (AE) rate was 26.7% (4/15) and included cases of peritonitis, bleeding, and stent migration. Reinterventions were performed in three patients with benign strictures and two with malignant strictures. Conclusions EUS-PD was an appropriate treatment for not only benign strictures but also malignant strictures with recurrent pancreatitis after failed ERP. However, the AE rate was high, and reinterventions were required in some cases during long-term follow-up. The indications for EUS-PD should be considered carefully, and careful follow-up is needed.


Endoscopy | 2017

Comparison of two fluoroscopic images to ensure efficient scope insertion for biliary intervention in patients with Roux-en-Y hepaticojejunostomy

Koichiro Tsutsumi; Hironari Kato; Ken Hirao; Sho Mizukawa; Shinichiro Muro; Yutaka Akimoto; Daisuke Uchida; Kazuyuki Matsumoto; Takeshi Tomoda; Shigeru Horiguchi; Shuntaro Yabe; Hiroyuki Seki; Yasuhiro Noma; Naoki Yamamoto; Ryo Harada; Tsuneyoshi Ogawa; Hiroyuki Okada

Background and study aims No standard procedure for endoscopic retrograde cholangiopancreatography is available for patients with Roux-en-Y hepaticojejunostomy (RYHJ) with side-to-end hepaticojejunostomy. We therefore explored methods of efficient scope insertion at a hepaticojejunostomy site. Patients and methods Patients with suspected biliary disease were prospectively enrolled. Based on two fluoroscopic images obtained on scope insertion into each lumen of a two-pronged Roux-en-Y anastomosis, we selected the lumen in which the distal end of the scope progressed toward the patients liver or head. The accuracy of this method for selecting the correct lumen leading to the hepaticojejunostomy site was investigated. Results Of the 33 included patients, successful insertion to the hepaticojejunostomy site was achieved in 32 (97 %), 26 (81 %) of whom had undergone the imaging method. The accuracy of the method was 88 % (23/26). The time required for insertion between the anastomotic site and the hepaticojejunostomy site was shorter when the lumen selection had been correct (13 minutes [7 - 30] (n = 23) vs. 18 minutes [8 - 28] (n = 9); P = 0.95). Conclusion This method based on two fluoroscopic images was useful for achieving efficient scope insertion in patients with RYHJ.Trial registered at University Hospital Medical Information Network Clinical Trials Registry (UMIN000014183).


Scandinavian Journal of Gastroenterology | 2014

An expanded training program for endosonographers improved self-diagnosed accuracy of endoscopic ultrasound-guided fine-needle aspiration cytology of the pancreas

Ryo Harada; Hironari Kato; Soichiro Fushimi; Masaya Iwamuro; Hirofumi Inoue; Shinichiro Muro; Ichiro Sakakihara; Yasuhiro Noma; Naoki Yamamoto; Shigeru Horiguchi; Koichiro Tsutsumi; Hiroyuki Okada; Kazuhide Yamamoto

Collaboration


Dive into the Shinichiro Muro's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge